Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. ARx LLC
FDA Inspection
•ARx LLC•March 29, 2019

ARx LLC – FDA Inspection, Mar 29, 2019

Record Details

This FDA Inspection record concerns ARx LLC, with an inspection on March 29, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
ARx LLC
Inspection Date
March 29, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Alice S. Tsao (FDA Associated Person)
  • Craig D. Zagata (FDA Associated Person)
  • James Norman (Issuing Officer)
  • John M. Mastalski (Issuing Officer)
  • Simone E. Pitts (FDA Associated Person)
View Company Profile

ID · f4e0ac1e-0e56-4d84-85aa-50b9a1eef37c

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1085673
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued

FDA Citations

9
  1. 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
  2. 21 CFR 211.165(e)Test methods
  3. 21 CFR 211.166(a)Lack of written stability program
  4. 21 CFR 211.180(b)Record maintenance 1 year (except exempt OTC)
  5. 21 CFR 211.192No written record of investigation
  6. 21 CFR 211.67(b)Written procedures not established/followed
  7. 21 CFR 211.67(b)(2)Cleaning SOPs/schedules
  8. 21 CFR 211.68(a)Calibration/Inspection/Checking not done
  9. 21 CFR 211.68(b)Computer control of master formula records

Full citation text and observation details available on the Dashboard.

Other FDA inspections of ARx LLC

8
DateClassificationOfficeProject area
June 10, 2026Not classifiedPhiladelphia District OfficeDrug Quality Assurance
June 3, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 20, 2021NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 18, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 18, 2014NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for ARx LLC
  • FDA Inspection 1306890 - 2026-06-10
  • FDA Inspection 1170966 - 2022-06-03
  • FDA Inspection 1151907 - 2021-08-20
  • FDA Inspection 988507 - 2016-08-18
  • FDA Inspection 867422 - 2014-02-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore ARx LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.